Galera Lays Off 70% of Staff After FDA Rejection in Severe Oral Mucositis

[cafead]

via The FDA rejected on Wednesday Galera Therapeutics’ avasopasem manganese, which the company was proposing as a treatment for radiotherapy-induced severe oral mucositis in patients with head and neck cancer.

article source